Unlike a normalized postoperative CEA level, an elevated postoperative CEA level is an independent adverse prognostic factor in lung cancer patients undergoing surgery, especially in lung adenocarcinoma. The gene discussed is CEACAM5; the disease is lung adenocarcinoma.